According to That’s Nice, the health of the contract development and manufacturing market correlates directly with the health of the overall pharma industry – and the good news is that both sectors are fairing well. For CDMOs, however, competition in the marketplace is strong, and many sponsors (52 percent) are looking to decrease their outsourcing spend over the next five years.
Here, we present a snapshot of the outsourcing sector based on the 2017 Nice Insight Contract Development and Manufacturing Report (1). The report is based on a survey of over 700 pharma industry professionals.

References
- Nice Insight, Contract Development and Manufacturing Report (2017). Available to purchase at www.pharmasalmanac.com/industry-reports.